Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$70.47MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- James Anthony Cacioppo
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1,288
- Beta
- 0.86
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -1.45
Financials
Revenue
$70.47M+21883.7%Net Income
$-12.52MEBITDA
$3.51MFree Cash Flow
$3.64M+7131939.6%EPS (diluted)
$-0.06Shares Outstanding (diluted)
198.20M+8140.8%Operating Expenses
$28.75MCash & Debt
$28.73MRevenue by Segment (annual)
$235.47MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $262.91M | $-68.59M | $-0.35 |
| 2024 | $257.52M | $-48.78M | $-0.25 |
| 2023 | $269.44M | $-65.10M | $-0.33 |
| 2022 | $284.28M | $-202.32M | $-1.06 |
| 2021 | $209.29M | $20.25M | $0.12 |
| 2020 | $80.77M | $-210.61M | $-1.94 |
| 2019 | $7.68M | $-31.32M | $-0.38 |
| 2018 | $570.9K | $-87.1K | $-0.46 |
| 2017 | $0.00 | $-64.9K | $-0.03 |
| 2016 | $0.00 | $-7.14M | $-2.97 |
| 2015 | $0.00 | $-746.3K | $-0.31 |
| 2014 | $0.00 | $-1.32M | $-0.55 |
| 2013 | $0.00 | $-1.49M | $-0.62 |
| 2012 | $0.00 | $-3.34M | $-1.38 |
Valuation
JUSHFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
10-80.00%Social Signal Score
Mentions (5)
- Newsglobenewswire.com·19d ago·Negative
Jushi Holdings Inc. Announces Receipt of DEA Registrations for State-Licensed Medical Cannabis Operations BOCA RATON, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, today announced that it has received registrations from the U.S. Drug Enforcement Administration (“DEA”) for certain state-licensed medical marijuana operations as part of the initial issuance of federal regis
View source ↗ - Newsseekingalpha.com·25d ago·Positive
Jushi Holdings Inc. (JUSH) Q3 2026 Earnings Call Transcript Jushi Holdings Inc. (JUSH) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·25d ago·Negative
Jushi Holdings Inc. (JUSHF) Reports Q3 Loss, Misses Revenue Estimates Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.12 per share a year ago.
View source ↗ - Newsglobenewswire.com·25d ago·Neutral
Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results Revenue Increased 7% Year-over-Year to $70.5 Million, With Growth Across Wholesale and Retail Channels
View source ↗ - Newsglobenewswire.com·39d ago·Neutral
Jushi Holdings Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026 BOCA RATON, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the third quarter ended September 30, 2026, after the market closes on Wednesday, October 28, 2026.
View source ↗
Earnings
Typical surprise -33.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$-0.04 vs $-0.06beat
- Tue, May 12$-0.10 vs $-0.06miss
- Tue, Mar 31$-0.08 vs $-0.06miss
- Tue, Nov 4$-0.12 vs $-0.05miss
- Tue, Aug 5$-0.06 vs $-0.06beat
- Thu, May 8$-0.09 vs $-0.06miss
Estimates and results for JUSHF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in JUSHF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
